Skip to main content
Clinical Trials/NCT03670875
NCT03670875
Completed
Not Applicable

Non-Pharmacologic Alternatives for the Treatment of Childhood Obesity in Mexico

Coordinación de Investigación en Salud, Mexico1 site in 1 country300 target enrollmentJuly 31, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Obesity in Childhood
Sponsor
Coordinación de Investigación en Salud, Mexico
Enrollment
300
Locations
1
Primary Endpoint
Loosing weight
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Childhood obesity is a global health issue. Mexico has been considered as the country with the higher number of children with obesity. There are not approved drugs to support diet and exercise as the first step to lose weight. Animal models and clinical trials in adults have provided evidence about safety and efficacy of interventions such as: prebiotics, curcumin, and omega- 3 fatty acids. The hypothesis of this study is: that non-pharmacological alternatives could support diet and exercise to decrease the weight of children with obesity.

Detailed Description

The aim of this study is to determinate the efficacy and safety of agave inulin, curcumin, and omega-3 fatty acids (O3FA) to decrease the weight of children with obesity. Design. Randomized controlled clinical trial (RCT) with four study groups: agave inulin, curcumin, omega-3 fatty acids and a control group. All groups will receive instructions to decrease calories intake and do exercise. Children sent to the unit with a presumptive diagnosis of obesity will be considered as candidates to the RCT. Children accomplishing with inclusion/exclusion criteria will be randomized to one of the study groups. Sample size was calculated using a statistical power of 80%, alpha value of 0.05. A 15 % of difference, in the mean of weight reduction, between control group and intervention groups was considered. The estimated sample size was 75 subjects for each group. Weight, height, BMI, blood pressure, abdominal circumference and body fat percentage will be measured in months 0, 1, 2, and 3. In months 0 and 3 a fasting venous blood sample will be drawn to perform the following test: glucose, insulin, lipid profile and C- Reactive protein, aspartate aminotransferase (AST) and alanine aminotransferase (ALT). Anthropometric measures, food intake recommendation and diaries of food consume will be performed by trained nutritionists. Recommendation about type of exercise and estimation of calories consumed will be performed by a physical education teacher. The statistical analysis will performed by one to the investigators blinded to treatment groups. Numerical values will be expressed as mean ± standard deviation. Categorical variables will be expressed as proportions. The analysis will be preformed according with CONSORT group recommendations Differences between the groups were estimated using one-way ANOVA with Bonferroni post-hoc test for numerical parameters and χ 2 test for categorical variables. Intragroup differences will be assessed by paired Student t test (Mann-Whitney U test for skewed data). Statistical significance will be considered as a p value \<0.05 and 95% confidence interval (CI). Statistical Package for the Social Sciences will be used for the analysis

Registry
clinicaltrials.gov
Start Date
July 31, 2021
End Date
December 30, 2022
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Coordinación de Investigación en Salud, Mexico
Responsible Party
Principal Investigator
Principal Investigator

Fernando Guerrero Romero MD

Head of the research unit

Coordinación de Investigación en Salud, Mexico

Eligibility Criteria

Inclusion Criteria

  • Gender: Boys and Girls
  • Diagnosis of obesity (percentile ≥ 95% according to The Centers for Disease Control and Prevention growth charts)
  • Informed consent of parents
  • Informed assent of the participant
  • Exclusion criteria:
  • Thyroid disease
  • Renal disease
  • Hepatic disease
  • Neoplasia disease
  • Chronic gastrointestinal conditions

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Loosing weight

Time Frame: Three months

Weight lost between basal and third month visits. Determined by a digital scale

Study Sites (1)

Loading locations...

Similar Trials